Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine A Chappell, MD
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wits Reproductive Health and Hiv Institute
Hillbrow, Johannesburg, South Africa
- Centre for the Aids Programme of Research in South Africa - Vululindlela
Pietermaritzburg, KwaZulu-Natal, South Africa
- the Aurum Institue - Tembisa #4
Tembisa, South Africa
- Magee-Womens Hospital of Upmc
Pittsburgh, Pennsylvania, United States
- Harare Health and Research Consortium
Chitungwiza, Zimbabwe
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2024
- Primary completion
- 24 Jan 2025
- Completion
- 24 Jan 2025
- Last update posted
- 3 Mar 2025
- Registered enrollment
- 93
- Registry id
- NCT06163274
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.